There is strong evidence from a variety of sources that forms of the bird flu virus circulating in Indonesia are more virulent than those elsewhere and that in a few cases they may have spread directly from one person to another. The WHO has tried for two years to accommodate Indonesia, without success. Under pressure from scientists worldwide, Indonesia agreed in June to share genetic data on some of its viral samples, but not the actual microbes. Without access to the viruses, it is impossible to verify the accuracy of such genetic information or to develop vaccines against the deadly microbes.
Outrageously, Supari has charged that the WHO would give any viruses — not just H5N1 — to drug companies, which in turn would make products designed to sicken poor people, in order “to prolong their profitable business by selling new vaccines” (a charge oddly reminiscent of the plot of John le Carre’s novel The Constant Gardener). The WHO elicited pledges from the world’s major drug companies not to exploit international repositories of genetic data for commercial benefit, but this has not satisfied Indonesia.
Indonesia’s claim that NAMRU-2 is a biological weapons facility must be confronted head-on. US Ambassador to Indonesia Cameron Hume is actively trying to prevent a catastrophe. So far, there has been insufficient support from senior US officials. They must get involved. And China must use its substantial influence with Indonesia on this issue — in its own self-interest.
Failure to share potentially pandemic viral strains with world health agencies is morally reprehensible. Allowing Indonesia and other countries to turn this issue into another rich-poor, Islamic-Western dispute would be tragic — and could lead to a devastating health crisis anywhere and at any time.
Richard Holbrooke, a former US ambassador to the UN, is president of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria. Laurie Garrett is a senior fellow for global health at the Council on Foreign Relations.
COPYRIGHT: PROJECT SYNDICATE



